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Objective: Therapeutic hypothermia instituted within 6h of birth has been
shown to improve neurodevelopmental outcomes in term newborns with
moderate–to–severe hypoxic–ischemic encephalopathy (HIE). The
majority of infants who would beneﬁt from cooling are born at centers that
do not offer the therapy, and adding the time for transport will result in
delays in therapy, that may lead to suboptimal or no neuroprotection for
some patients. Our objective was to evaluate the effect of our center’s
experience with therapeutic hypothermia on neonatal transport.
Study Design: Retrospective review of all cases of therapeutic
hypothermia at a single neonatal intensive care unit from 2005 to 2009.
Result: Of 50 infants with HIE treated with hypothermia, 40 were
outborn and 35 were cooled on transport. The majority of patients were
passively cooled by the referring clinicians, then actively cooled by our
transport team. Overcooling to <321C occurred in 34% of patients, but
there were no signiﬁcant differences in admission vital signs or laboratory
values between overcooled and appropriately cooled infants. The average
time after birth of initiation of passive cooling was 1.4h and active cooling
was 2.7h compared with the time of admission to our unit of 5.9h.
Conclusion: We discuss the important aspects of our program, including the
education of referring and receiving clinicians and avoidance of overcooling.
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Introduction
Hypoxic–ischemic encephalopathy (HIE) affects approximately
1 per 1000 term newborns, with an estimated 20% mortality and
25% neurodevelopmental impairment in survivors.
1,2 Until recently,
treatment for neonates with HIE was limited to supportive
care and anticonvulsants for seizure control. In 2005, three
multicenter randomized controlled trials were published showing
that induction of mild hypothermia resulted in signiﬁcantly
improved neurodevelopmental outcome in neonates X36 weeks
gestation with acute perinatal HIE.
3–6
Timing of induction of hypothermia after an asphyxial brain
injury is critical for optimum neuroprotection. Studies in animal
models suggest that hypothermia should be started within 6h
of an acute asphyxial event, during the latent phase before the
onset of secondary cerebral energy failure. Studies in near-term
fetal sheep with a cerebral ischemic insult showed optimum
neuroprotection if hypothermia was induced within 90min
of reperfusion. Delayed hypothermia continued to show some
beneﬁt if started <5.5h after reperfusion but not if delayed until
8.5h, at which time animals were experiencing post-asphyxial
seizures.
7–9 There is also evidence that the duration of the latent
phase between primary and secondary energy failure is inversely
proportional to the severity of the ischemic insult, suggesting
that the therapeutic window for starting hypothermia therapy
may be even shorter than 6h in profound asphyxial insults.
10
On the basis of these and other studies, most clinical trials
of induced hypothermia for asphyxiated neonates have begun
treatment within 6h of birth.
Asphyxiated neonates have complex medical needs and
should be cared for in intensive care units that can provide
multidisciplinary subspecialty evaluation and treatment. Most
neonates who meet the criteria for hypothermia therapy will
be born in hospitals that do not provide this high level of care.
As the time to transport patients to regional neonatal intensive
care units (NICUs) offering hypothermia therapy may exceed
the therapeutic window for neuroprotection, some centers have
implemented cooling during neonatal transport. In the pilot study
of Eicher et al. published in 2005, in which our center participated,
outborn infants randomized to hypothermia were cooled with
ice packs during transport. Two more recent clinical trials, TOBY
(total body cooling) and ICE (Infant Cooling Evaluation), cooled
some neonates during transport. The TOBY trial allowed for
cooling to 33 to 341C during neonatal transport, unless it was
likely that the infant would be transferred by 3h after birth. Passive
cooling was achieved by turning off the radiant warmer and, if
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target temperature.
11 A similar approach to inducing hypothermia
during transport was used in the ICE trial.
12 Passive cooling during
neonatal transport (withholding external heat sources) was
described in a case report of two infants with HIE whose rectal
temperatures on arrival to the tertiary NICU were 34.3 and
33.41C.
13 In a recent report, passive cooling was used
in 18 babies during transport to a regional hypothermia center.
14
On arrival, only four babies had temperatures in the desired range
of 33 to 351C, whereas eight had admission temperature in the
35 to 371C range, and six were overcooled. Passive overcooling
can be a signiﬁcant problem, particularly in severely asphyxiated
neonates in whom temperature is only intermittently monitored.
15
These reports highlight the need for education, experience,
and perhaps new protocols for achieving target neuroprotective
temperatures during neonatal transport.
Hypothermia for perinatal HIE is a relatively new, evolving
therapy and research into long-term outcomes and other issues is
ongoing. In 2006, the National Institutes of Child Health and
Human Development issued a statement recommending that
centers choosing to offer hypothermia therapy do so only in the
context of protocols published in larger clinical trials and with
systematic data collection.
16 In 2008, we published our ﬁrst 2 years’
experience with implementing a hypothermia for HIE program in
our NICU,
17 and in the current report, we describe our 4 year’s
experience with therapeutic hypothermia during neonatal transport.
Methods
In March 2005, the University of Virginia (UVA) NICU instituted
a protocol for therapeutic hypothermia for neonates with
moderate to severe HIE. The eligibility criteria are similar to
those used in published randomized controlled trials, including
infants X36 weeks gestation and p6h of age at the start
of therapy with at least one indicator of an acute perinatal
hypoxic–ischemic event and at least two indicators of moderate
or severe encephalopathy on physical examination. Exclusion
criteria are severe sepsis with shock or active bleeding.
Parents receive verbal and written information about HIE
and hypothermia therapy, but signed parental consent is not
required.
The UVA NICU serves as a regional referral center for
10 hospitals and B40% of admissions are outborn. The median
one-way travel distance to our referring hospitals is 64 miles
(range 3 to 160 miles) and 95% of transports are accomplished
by ground. Several NICUs beyond our referral region that do not
offer hypothermia therapy also refer patients to our center for
cooling. As many outborn patients qualifying for hypothermia
therapy would not arrive at the UVA NICU before 6h of age, it was
decided that therapy would begin at the referring hospital and
continue during transport. After developing written protocols for
hypothermia therapy on transport, education sessions were held for
referring clinicians through our Perinatal Continuing Education
Program.
18 Additional training sessions were held with the UVA
Neonatal Emergency Transport System clinicians, which includes
specially trained NICU nurses, respiratory therapists and emergency
medical technicians. Training sessions focused on (1) rationale for
hypothermia and clinical trial results, (2) eligibility and exclusion
criteria, (3) neurological examination ﬁndings of moderate to
severe HIE and (4) practical aspects of passive and active cooling
before and during the transport. Passive cooling by the referring
clinicians was recommended in the ﬁrst 2 years of our program.
Since 2007, level III NICUs, which refer patients for hypothermia
therapy, have begun active cooling while awaiting arrival of our
transport team, but all other centers continue to use passive
cooling only.
The typical sequence of events for initiating hypothermia
therapy for outborn infants referred to our center is as follows:
(1) Outreach education to referring clinicians includes a
recommendation to turn off the radiant warmer as soon as the
diagnosis of acute perinatal moderate to severe HIE is considered
(with temperature monitoring at least every 15min).
(2) When an infant is born with suspected acute perinatal HIE, the
referring clinician calls the neonatology attending or fellow to
arrange transfer.
(3) The UVA Neonatal Emergency Transport System team is
dispatched.
(4) Criteria for an acute perinatal hypoxic–ischemic event and
physical examination evidence of moderate or severe
encephalopathy are discussed.
(5) If the infant meets the criteria for therapeutic hypothermia,
a recommendation is made to continue passive cooling and
closely monitor the rectal temperature (at least every 15min,
or continuously if possible). Active cooling in primary care
hospitals before arrival of the transport team is discouraged.
(6) The UVA transport team arrives at the referring hospital and
initiates continuous rectal temperature monitoring.
(7) If necessary, cool gel packs (B101C, wrapped in a cloth)
are brieﬂy applied to the head and/or trunk until the rectal
temperature is <341C (active cooling).
(8) The infant is placed in a room temperature transport incubator.
(9) The rectal temperature is continuously monitored during
transport and adjustments are made to maintain a target
temperature of 33 to 341C. Adjustments include placing a
receiving blanket on the baby if the rectal temperature drops
below 331C, or a wrapped cool gel pack if the temperature
rises above 341C. The air temperature of the transport
incubator is increased, if the patient’s rectal temperature
continues to fall despite covering with a blanket. A warm
gel pack is applied if the temperature drops below 311C
and removed once the temperature rises above 321C.
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undergoing hypothermia therapy in our center. The UVA
Institutional Review Board has approved the review of
de-identiﬁed patient information for publication. For this report, we
reviewed clinical data on all patients undergoing therapeutic
hypothermia in the ﬁrst 4 years of the program, from March 2005
to February 2009. Vital signs and laboratory values of outborn
infants on arrival to UVA were compared between infants who were
overcooled (minimum temperature before admission p321C,
n¼12) and those who remained closer to target temperature
(minimum temperature >321C, n¼23), by unpaired, two-tailed
t-tests using GraphPad Prism version 4.03 (GraphPad Software,
La Jolla, CA, USA), with signiﬁcance set at P<0.05. Data are
presented as mean±s.d. unless otherwise indicated.
Results
A total of 50 infants underwent hypothermia therapy for moderate
to severe HIE in the UVA NICU from March 2005 to February 2009.
40 patients (80%) were born at referring hospitals. The UVA
Neonatal Emergency Transport System team transported 39 of these
patients (all by ambulance) and one patient was transported
by helicopter by the referring hospital’s neonatal transport team.
Of the 40 outborn patients, 35 underwent passive and/or active
cooling before and during the transport. Altogether, 25 patients
had passive cooling initiated by the referring clinicians (turning off
the radiant warmer). For 23 of these patients, active cooling
(applying cool packs) was initiated by our transport team
at the referring hospital and continued during transport, and the
other 2 patients continued with passive cooling during transport
(one with a very short transport time and one transported by
helicopter by the referring hospital team). 10 patients at level III
referring NICUs had active cooling initiated by the referring
neonatologists before the arrival of our transport team. Five
outborn patients were not cooled until arrival at our center, either
because hypothermia was not considered until the infant was
assessed at our NICU (four patients, three in the ﬁrst year of the
program) or the transport time was very short (one patient). One
patient who qualiﬁed for hypothermia therapy was excluded
because of shock and disseminated intravascular coagulation with
active bleeding.
Figure 1 compares the cooling start time for inborn and outborn
patients and the hours of age on arrival to the UVA NICU. The time
of arrival of the UVA transport team to the referring hospital was
2.9±1.4h after birth (range 0.37 to 5.5h). The ﬁrst rectal
temperature recorded by our transport team after arrival at the
referring hospital was 34.7±2.01C. The patients who were actively
cooled at the referring NICU (n¼10) had rectal temperature
33.9±2.11C when our transport team arrived at the referring
hospital, compared with 34.4±1.91C in the infants passively
cooled (n¼25) and 36.6±0.31C in those undergoing
conventional thermal management (n¼5). The time from birth
to achieve core temperature <341C was 2.6±1.8h for inborn
infants (n¼10), 3.9±1.6h for infants cooled before and during
transport (n¼35), and 9.8±6.2h for outborn infants not cooled
until the arrival at our unit (n¼5). As shown in Figure 1, one
patient admitted in the ﬁrst year of the hypothermia program
was not cooled until 19h of age due to a late decision to
initiate therapy.
Figure 2 shows the rectal temperature for outborn patients
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Figure 1 Cooling start time and the University of Virginia (UVA) arrival
time. A total of 50 infants underwent hypothermia therapy at the UVA Neonatal
Intensive Care Unit from March 2005 to February 2009. Cooling start time
is shown for inborn infants (hours after birth, n¼10, ﬁlled squares). Of the
40 outborn infants, 35 were cooled before and during transport, and 5 were
not cooled until arrival at UVA (ﬁlled triangles). Cooling was classiﬁed as passive
(no external heat source, ﬁlled circles) or active (application of cool gel packs,
ﬁlled diamonds). Some infants underwent passive followed by active cooling and
both start times are included. The arrival time at UVA for all 40 outborn infants is


































Not cooled on transport
Passive cooling only on
transport
Figure 2 Comparison of temperature of 40 outborn neonates with hypoxic–
ischemic encephalopathy (HIE) before and after neonatal transport. The rectal
temperatures of 40 outborn infants on arrival of the University of Virginia (UVA)
transport team to the referring hospital and on arrival of the patients to the UVA
Neonatal Intensive Care Unit. Five patients were not cooled until after arrival
to UVA, two patients underwent passive cooling only and thirty-three patients
underwent active cooling during transport.
Hypothermia therapy on neonatal transport
K Fairchild et al
326
Journal of Perinatologythe temperature on arrival to our unit. The UVA admission
rectal temperature range was 29.2 to 34.41C for the 33 infants
actively cooled on transport, 34.4 to 34.81C for the two infants
passively cooled on transport and 36.5 to 38.11C for the ﬁve
infants not cooled on transport.
Admission characteristics of the 50 infants in our therapeutic
hypothermia program March 2005 to February 2009 are
summarized in Table 1. Of the 35 infants cooled before and during
transport, 23 (66%) maintained temperatures in the range 32 to
351C over the course of the entire transport. Five infants (14%)
had at least one core temperature <301C, and the duration of
temperature <301C was 1.0±0.6h. Seven infants (20%) had at
least one core temperature between 30 and 321C, and the duration
of temperature in this range was 1.6±1h. No cardiac arrhythmias
other than sinus bradycardia were noted in any patient. When
comparing patients who were overcooled to <321C( n¼12)
with those who maintained temperature in the 32 to 351C range
(n¼23), there was a trend toward lower birth weight in those
infants who were overcooled (2948±722g vs 3284±693g,
P¼0.18). There were no signiﬁcant differences in admission
vital signs or laboratory tests between the groups, although there
was a trend toward lower platelet counts (143±45 vs 193±18,
P¼0.06) and higher blood sugar (189±101 vs 139±65,
P¼0.08) in overcooled infants vs appropriately cooled
infants, respectively.
Figure 3 shows, by year, the UVA admission temperature for
patients cooled on transport. The mean admission temperature

















Gestational age (weeks) 38.8±1.1 38.1±2.7 38.8±1.1 38.0±2.6 38.5±1.9 37.9±2.2
Birth weight (g) 2914±415 2973±917 3284±693 3853±971 3228±750 3197±845
Degree of encephalopathy
(moderate/severe)
2/3 3/4 16/7 3/2 24/16 4/6
Age at start of cooling, passive
or active (h)
1.9±1.3 2.5±1.5 3.0±1.6 8.1±6.5 3.5±3.2 0.9±0.7
Age at arrival of transport
team (h)
2.6±1.2 2.7±1.5 3.0±1.4 2.8±1.8 2.9±1.4 N/A
Age at arrival to UVA (h) 6.1±1.0 5.8±2.2 6.1±2.0 5.8±2.9 5.9±2.1 N/A
Age when temperature reached
<341C (h)
3.2±1.7 3.4±0.4 4.3±2.0 9.8±6.1 4.7±3.2 2.6±1.8
HR (bpm) 111±23 104±16 113±20 147±31 116±24 143±13
Blood pressure (mean, mmHg) 55±74 9 ±65 0 ±11 53±55 1 ±11 43±7
Platelet count (kml
 1) 136±32 146±56 193±84 234±110 183±82 207±81
PT (s) 21.9±5.1 27.0±8.9 24.9±10.7 21.6±8.8 24.5±9.7 26.0±5.8
INR 1.8±0.5 2.3±0.9 2.0±1.2 2.0±1.1 2.1±1.1 2.2±0.5
AST (Ul
 1) 121±80 398±597 575±1082 260±209 451±866 316±391
ALT (Ul
 1)4 0 ±22 343±714 211±273 110±165 208±423 91±108
Creatinine (mg per 100ml) 0.8±0.2 1.1±0.1 0.9±0.3 1.3±0.6 1.0±0.3 0.9±0.1
Glucose (mg per 100ml) 191±88 188±116 139±65 73±16 142±82 143±90
Abbreviations: N/A, not applicable; UVA, University of Virginia; HR, heart rate; PT, prothrombin time; INR, international normalized ratio; AST, aspartate aminotransferase; ALT, alanine
aminotransferase.

































Figure 3 The University of Virginia (UVA) admission temperature for 35 outborn
infants cooled on transport. The rectal temperatures of 35 outborn infants cooled
during transport, recorded on admission to the UVA Neonatal Intensive Care
Unit. Gray-shaded area represents target temperature (33 to 341C). Two patients
with only passive cooling during transport (indicated with an open circle)
had admission temperatures of 34.4 and 34.81C. All others were transported
with active cooling.
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the target range of 33 to 341C.
Discussion
The timing of initiation of therapeutic hypothermia is critical, with
animal studies showing optimum neuroprotection, if hypothermia
is induced within B6h of an acute asphyxial insult. In our
center, 80% of newborns eligible for hypothermia therapy from
2005 to 2009 were born at the referring hospitals, and nearly
half of the outborn patients arrived at our center >6h after birth.
Initiating hypothermia therapy at the referring hospital resulted in
an average time savings of B3h, which in some cases may result
in improved outcomes. In this report, we highlight our efforts to
educate health-care providers about passive and active cooling of
neonates with HIE and share suggestions for avoiding overcooling.
Key points in the implementation of a hypothermia therapy on
transport program are summarized in Table 2.
Educating referring clinicians about when and how to initiate
therapeutic hypothermia is a cornerstone to a successful program.
We recommend that in cases of acute perinatal distress with
suspected HIE, the radiant warmer should be turned off and the
baby’s temperature closely monitored during initial stabilization
and neurological assessment. If the neurological examination is
not consistent with moderate to severe encephalopathy, the baby
can then be transitioned to routine thermal care. If the baby meets
criteria for therapeutic hypothermia, passive cooling is continued
until the arrival of our transport team. Asphyxiated, encephalopathic
newborns are notoriously poor at thermoregulation and some will
passively cool to a core temperature in the 33 to 341Cr a n g ei f
left uncovered at room temperature.
15 In fact, in some cases in
our series, passive cooling resulted in temperatures below the target
range. On the other hand, passive cooling did not achieve optimum
neuroprotective temperatures in many patients, with 40% of patients
having rectal temperature >351C on arrival of our transport team
and 20% with temperature >371C.
Active cooling of neonates with HIE can be accomplished
with brief application of a wrapped cool gel pack. In general this,
is done by our neonatal transport team, but several level III
NICUs referring patients to our center have begun active cooling
before the arrival of our team. In either case, it is important
to continuously monitor rectal temperature and remove the cool
pack when temperature falls below 341C to avoid overcooling.
In our experience, active cooling resulted in at least one recorded
temperature <301C in 14% of patients and <321C in 34%.
Most patients who were overcooled had only intermittent rather
than continuous rectal temperature monitoring, and had ice packs
(B0t o41C) applied rather than cool gel packs (B7t o1 01C).
Although we did not see statistically signiﬁcant differences in
admission vital signs or laboratory values in overcooled compared
with appropriately cooled patients, the number of patients in
each group was too small to draw any conclusions about the
detrimental effects of overcooling. There were trends toward lower
platelet counts and higher blood sugar in the overcooled groups,
which, if borne out in larger numbers of patients, could be a result
of the hypothermia or simply an indicator of a more severe degree
of asphyxia. We did ﬁnd that overcooled patients were more likely
to be classiﬁed as severe, rather than moderate, encephalopathy,
possibly contributing to a more deranged thermoregulatory
state. In any case, efforts should be made to avoid overcooling
neonates, and we found that use of continuous rectal temperature
monitoring and judicious use of cooling packs has resulted in
more patients arriving at our center in the target temperature
range in recent years (Figure 3). Neonatal transport teams
instituting a new protocol for induced hypothermia should consider
beginning with either passive cooling or active cooling targeting
a slightly higher temperature to avoid overcooling during the start-
up phase.
As therapeutic hypothermia is increasingly used for neonates
with HIE, whether and how to cool patients before arrival to a
hypothermia center will be an important issue to resolve. Results
of recently completed clinical trials, which cooled some babies
during transport to study centers, are likely to provide important
information about this practice. We have found that, with
experience and education, our referring and transport clinicians
can induce and maintain hypothermia for asphyxiated neonates
before and during transport. Neuroprotective temperatures are
often achieved several hours sooner with this approach, and efforts
to develop and evaluate protocols for safe transport of neonates
undergoing induced hypothermia are warranted.
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